Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Julie Wessels
High Cutoff Versus High-Flux Haemodialysis for Myeloma Cast Nephropathy in Patients Receiving Bortezomib-Based Chemotherapy (EuLITE): A Phase 2 Randomised Controlled Trial
The Lancet Haematology
Hematology
Related publications
Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib
Blood Cancer Journal
Oncology
Hematology
Response-Adapted Intensification With Cyclophosphamide, Bortezomib, and Dexamethasone Versus No Intensification in Patients With Newly Diagnosed Multiple Myeloma (Myeloma XI): A Multicentre, Open-Label, Randomised, Phase 3 Trial
The Lancet Haematology
Hematology
Effects of a Self-Managed Home-Based Walking Intervention on Psychosocial Health Outcomes for Breast Cancer Patients Receiving Chemotherapy: A Randomised Controlled Trial
Supportive Care in Cancer
Oncology
Leptotrichia Bacteremia in Patients Receiving High-Dose Chemotherapy
Journal of Clinical Microbiology
Microbiology
Phenytoin for Neuroprotection in Patients With Acute Optic Neuritis: A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology
Neurology
Nadroparin or Fondaparinux Versus No Thromboprophylaxis in Patients Immobilised in a Below-Knee Plaster Cast (PROTECT): A Randomised Controlled Trial
Injury
Surgery
Orthopedics
Sports Medicine
Emergency Medicine
Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial
The Lancet Oncology
Oncology
Furosemide Versus Mannitol in Japanese Patients With Thoracic Malignancy Who Received Cisplatin-Based Chemotherapy Using Short Hydration: Study Protocol for a Randomised Controlled Trial
BMJ Open
Medicine
Phase II Study of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
British Journal of Haematology
Hematology
